{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:47:59Z","timestamp":1785908879978,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSF23AK"],"award-info":[{"award-number":["JPMJSF23AK"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2134"],"award-info":[{"award-number":["JPMJSP2134"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24053"],"award-info":[{"award-number":["23K24053"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jphs.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:45:52Z","timestamp":1781541952000},"page":"40-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human blood\u2013brain barrier spheroid models for the evaluation of drugs targeting brain vascular inflammation"],"prefix":"10.1016","volume":"162","author":[{"given":"Ayuka","family":"Ebisawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Morio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Minasato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furano","family":"Kunitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3614-9328","authenticated-orcid":false,"given":"Tomomi","family":"Furihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jphs.2026.06.005_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuron.2011.08.009","article-title":"Role of astrocytes in neurovascular coupling","volume":"71","author":"Petzold","year":"2011","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jphs.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12035-012-8244-2","article-title":"Neurovascular unit: a focus on pericytes","volume":"45","author":"S\u00e1-Pereira","year":"2012","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"10.1016\/j.jphs.2026.06.005_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.jphs.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.immuni.2013.02.012","article-title":"Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus","volume":"38","author":"Shechter","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jphs.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri.2017.100","article-title":"Organ-specific protection mediated by cooperation between vascular and epithelial barriers","volume":"17","author":"Spadoni","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jphs.2026.06.005_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fnins.2017.00224","article-title":"Development and function of the blood-brain barrier in the context of metabolic control","volume":"11","author":"Haddad-T\u00f3volli","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jphs.2026.06.005_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.jphs.2026.06.005_bib9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.118.310822","article-title":"MicroRNA-Mediated therapy modulating blood-brain barrier disruption improves vascular cognitive impairment","volume":"38","author":"Toyama","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jphs.2026.06.005_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/STROKEAHA.122.040578","article-title":"Blood-brain barrier dysfunction in normal aging and neurodegeneration: mechanisms, impact, and treatments","volume":"54","author":"Andjelkovic","year":"2023","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib11","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1530\/VB-19-0033","article-title":"Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation","volume":"2","author":"Marchetti","year":"2020","journal-title":"Vasc Biol"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","article-title":"Roles of neuropathology-associated reactive astrocytes: a systematic review","volume":"11","author":"Lawrence","year":"2023","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.jphs.2026.06.005_bib13","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms26062440","article-title":"Impact of peripheral inflammation on blood-brain barrier dysfunction and its role in neurodegenerative diseases","volume":"26","author":"Beltran-Velasco","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2026.06.005_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/164_2021_562","article-title":"Human blood-brain-barrier in vitro models: overview and applications","volume":"273","author":"Cader","year":"2022","journal-title":"Handb Exp Pharmacol"},{"issue":"8","key":"10.1016\/j.jphs.2026.06.005_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/j.jphs.2026.06.005_bib16","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1039\/c2lc40089h","article-title":"Microengineered physiological biomimicry: organs-on-chips","volume":"12","author":"Huh","year":"2012","journal-title":"Lab Chip"},{"key":"10.1016\/j.jphs.2026.06.005_bib17","article-title":"Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development and precision medicine","author":"Li","year":"2025","journal-title":"Protein Cell"},{"issue":"7","key":"10.1016\/j.jphs.2026.06.005_bib18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1248\/bpb.b21-00218","article-title":"Development, characterization and potential applications of a multicellular spheroidal human blood-brain barrier model integrating three conditionally immortalized cell lines","volume":"44","author":"Kitamura","year":"2021","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"10.1016\/j.jphs.2026.06.005_bib19","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1021\/acs.molpharmaceut.2c00120","article-title":"Human immortalized cell-based blood-brain barrier spheroid models offer an evaluation tool for the brain penetration properties of macromolecules","volume":"19","author":"Kitamura","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jphs.2026.06.005_bib20","article-title":"EBI2-oxysterol signalling regulates VE-cadherin expression and multiple sclerosis CD4+ T cell attachment to a human tri-cell spheroid blood-brain barrier model","volume":"47","author":"Caratis","year":"2025","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/jnc.13358","article-title":"Establishment and characterization of a new conditionally immortalized human astrocyte cell line","volume":"136","author":"Furihata","year":"2016","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.jphs.2026.06.005_bib22","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1007\/s12035-017-0815-9","article-title":"A new conditionally immortalized human fetal brain pericyte cell line: establishment and functional characterization as a promising tool for human brain pericyte studies","volume":"55","author":"Umehara","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.jphs.2026.06.005_bib23","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1021\/acs.molpharmaceut.9b00519","article-title":"A human immortalized cell-based blood-brain barrier triculture model: development and characterization as a promising tool for drug-brain permeability studies","volume":"16","author":"Ito","year":"2019","journal-title":"Mol Pharm"},{"issue":"15","key":"10.1016\/j.jphs.2026.06.005_bib24","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.4465","article-title":"Generation of a human conditionally immortalized cell-based multicellular spheroidal blood-brain barrier model for permeability evaluation of macromolecules","volume":"12","author":"Isogai","year":"2022","journal-title":"Bio Protoc"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-018-1657-1","article-title":"ADAM-17 is expressed on rheumatoid arthritis fibroblast-like synoviocytes and regulates proinflammatory mediator expression and monocyte adhesion","volume":"20","author":"Ishii","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.jphs.2026.06.005_bib26","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.3390\/ijms26083532","article-title":"Breaking the barrier: the role of proinflammatory cytokines in BBB dysfunction","volume":"26","author":"Gryka-Marton","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jphs.2026.06.005_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318822","article-title":"Differential expression and modulation of EBI2 and 7\u03b1,25-OHC synthesizing (CH25H, CYP7B1) and degrading (HSD3B7) enzymes in mouse and human brain vascular cells","volume":"20","author":"Caratis","year":"2025","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jphs.2026.06.005_bib28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3174\/ajnr.A2226","article-title":"Natalizumab (Tysabri)","volume":"31","author":"Selewski","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"18","key":"10.1016\/j.jphs.2026.06.005_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.171371","article-title":"Endothelial cell-specific LAT1 ablation normalizes tumor vasculature","volume":"9","author":"Suehiro","year":"2024","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.jphs.2026.06.005_bib30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/biom12040553","article-title":"Therapeutic potential for intractable asthma by targeting L-Type amino acid transporter 1","volume":"12","author":"Hayashi","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.jphs.2026.06.005_bib31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jnc.13408","article-title":"Tumour necrosis factor-\u03b1-mediated disruption of cerebrovascular endothelial barrier integrity in vitro involves the production of proinflammatory interleukin-6","volume":"136","author":"Rochfort","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.jphs.2026.06.005_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146647","article-title":"Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-\u03b1) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model","volume":"1730","author":"Voirin","year":"2020","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43214-7","article-title":"Validation and characterization of a novel blood-brain barrier platform for investigating traumatic brain injury","volume":"13","author":"Bolden","year":"2023","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jphs.2026.06.005_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810235","article-title":"TNF-\u03b1 and IL-1\u03b2 modulate blood-brain barrier permeability and decrease Amyloid-\u03b2 peptide efflux in a human blood-brain barrier model","volume":"23","author":"Versele","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2026.06.005_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fncel.2019.00337","article-title":"Astrocytes modify migration of PBMCs induced by \u03b2-Amyloid in a blood-brain barrier in vitro model","volume":"13","author":"Spampinato","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jphs.2026.06.005_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2018.07.030","article-title":"A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-\u03b1 and IL-6 in an iPSC-based blood-brain barrier model","volume":"119","author":"Mantle","year":"2018","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140966","article-title":"Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging","volume":"131","author":"Propson","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jphs.2026.06.005_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib39","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jphs.2026.06.005_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.jphs.2026.06.005_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12974-024-03261-x","article-title":"Compromised endothelial Wnt\/\u03b2-catenin signaling mediates the blood-brain barrier disruption and leads to neuroinflammation in endotoxemia","volume":"21","author":"Huang","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.jphs.2026.06.005_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015478","article-title":"Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis","volume":"5","author":"Doerck","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jphs.2026.06.005_bib43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.arcmed.2014.11.013","article-title":"Role of the blood-brain barrier in multiple sclerosis","volume":"45","author":"Ortiz","year":"2014","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jphs.2026.06.005_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1101379","article-title":"The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis","volume":"17","author":"Angelini","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jphs.2026.06.005_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fncel.2015.00028","article-title":"Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration","volume":"9","author":"Sankowski","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jphs.2026.06.005_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.998023","article-title":"The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid","volume":"15","author":"Kutryb-Zajac","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"10.1016\/j.jphs.2026.06.005_bib47","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.21873\/invivo.12077","article-title":"Biomarker analyses in patients with advanced solid tumors treated with the LAT1 inhibitor JPH203","volume":"34","author":"Okano","year":"2020","journal-title":"In Vivo (Athens)"},{"issue":"12","key":"10.1016\/j.jphs.2026.06.005_bib48","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","article-title":"Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo","volume":"23","author":"Chiaradia","year":"2020","journal-title":"Nat Neurosci"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:10:24Z","timestamp":1785906624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861326000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1347861326000344"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2026.06.005","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human blood\u2013brain barrier spheroid models for the evaluation of drugs targeting brain vascular inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}